AI English summary of an SEC filing — figures as filed
L3Harris said Chair and Chief Executive Officer Christopher E. Kubasik established a written pre-arranged plan on July 29, 2024 for the exercise of employee stock options and the sale of shares of common stock issued upon exercise.
Key points
AI summaryL3Harris said Chair and Chief Executive Officer Christopher E. Kubasik established a written pre-arranged plan on July 29, 2024 for the exercise of employee stock options and the sale of shares of common stock issued upon exercise.
The company said the plan covers 56,624 vested options to purchase shares granted to Kubasik in February 2017, which expire in February 2027.
The company said shares underlying unexercised options will be sold on predetermined dates starting in October 2024 and ending no later than December 27, 2024, subject to minimum price thresholds specified in the plan.
The company said the plan complies with Rule 10b5-1 and its policies on executive securities transactions, was established during an open trading window, and gives Kubasik no discretion over sales. It said transactions will be disclosed on Form 4 and Form 144.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Kubasik, L3Harris Chair and CEO, Adopts Rule 10b5-1 Stock Trading Plan
L3Harris said Chair and Chief Executive Officer Christopher E. Kubasik established a written pre-arranged plan on July 29, 2024 for the exercise of employee stock options and the sale of shares of common stock issued upon exercise.
Source · Based on the filing body and exhibits
Plan Covers 56,624 Vested Options Granted in February 2017
The company said the plan covers 56,624 vested options to purchase shares granted to Kubasik in February 2017, which expire in February 2027.
Source · Based on the filing body and exhibits
Sale Schedule and Minimum Price Conditions
The company said shares underlying unexercised options will be sold on predetermined dates starting in October 2024 and ending no later than December 27, 2024, subject to minimum price thresholds specified in the plan.
Source · Based on the filing body and exhibits
Rule 10b5-1 Compliance, No Discretion, Disclosure Method
The company said the plan complies with Rule 10b5-1 and its policies on executive securities transactions, was established during an open trading window, and gives Kubasik no discretion over sales. It said transactions will be disclosed on Form 4 and Form 144.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…